Avertix was founded in 2001 by Drs. Robert, Tim and David Fischell,
active serial entrepreneurs and inventors of medical technologies. In
1999, the company filed its first of more than 50 issued US patents
relating to detecting cardiac events and patient alerting, with the
company’s first human implant occurring in 2005.
Our company has developed the Guardian System, which is the first and only FDA approved solution designed to detect and warn patients of acute thrombotic coronary occlusion.
CMS awarded the Guardian a Transitional Pass Through status in November 2021 which became effective January 1, 2022.
Ross Haghighat, Executive Chairman
Timothy P. Moran, President and Chief Executive Officer
Philip L. Tom, Executive Vice President and Chief Financial Officer
Peter Elia, Chief Revenue Officer
David L. Keenan, Chief Technology Officer
Sasha John, PhD., Chief Scientific Officer
Holly S. Windler, SVP, Global Marketing
BIOS Acquisition Corp.
For investor professional information please contact us
Avertix Data Presented at TCT 2023 Shows 150% Increase in Medication Adjustments of Antiarrhythmics for High-Risk Heart Attack Survivors
Avertix and BIOS Acquisition Corporation Mutually Agree to Terminate Proposed Business Combination
Avertix to Present at Two Upcoming Investor Conferences in September 2023
Heart & Rhythm Institute of Trinity and Avertix Announce Partnership to Improve Cardiac Care and Patient Monitoring
Renown Cardiologist and Professor Ian T. Meredith, MD to Join Avertix Medical’s Board of Directors
Avertix’s Guardian™ System, First and Only FDA-Approved Implantable Heart Attack Detection and Warning System, Now Available at AdventHealth Orlando
Avertix to Participate in the Sidoti Summer Small Cap Conference
Avertix Showcases Guardian at Three Prestigious Conferences
Avertix to Become Publicly Traded via Merger with BIOS
AngelMed is now Avertix
Avertix Announces CMS Approval of Transitional Pass-Through (TPT) Payment Category For The Guardian™
Avertix Announces First Commercial Implantation of Real-Time Heart Attack Warning System
Avertix Announces FDA Approval of the Enhanced Real-Time Cardiac Monitor for Acute Coronary Syndrome (ACS) Events
Cantor Fitzgerald Global Healthcare Conference
Sidoti Small Cap Conference
Sidoti Summer Small Cap Conference
Avertix is looking for employees who share our core values and
who are looking for a challenging career opportunity. We are
committed to finding, attracting, and retaining a talented
workforce. We reward expertise with professional growth and
opportunity, an excellent salary, and an extensive benefits
Avertix is committed to the success of every employee and that commitment begins with our first meeting. While you meet with senior managers and team members, be prepared to discuss how you can contribute to our organization. We will make every effort to determine if there is a good fit between your experience and career goals and our opportunities.
All resumes must be submitted through our Human Resources
to be considered for an available position. Be sure to reference
the staff requisition number (shown at the top of position pages)
when applying for a position with Avertix.
District Sales Manager
Therapy Development Manager
Avertix is an Equal Opportunity Employer.
To be considered for an opening: